Cancer Causes & Control

, Volume 29, Issue 12, pp 1265–1275 | Cite as

Promising practices for the prevention of liver cancer: a review of the literature and cancer plan activities in the National Comprehensive Cancer Control Program

  • Behnoosh MominEmail author
  • Alexander J. Millman
  • Danielle Beauchesne Nielsen
  • Michelle Revels
  • C. Brooke Steele
Original paper



Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections are risk factors for hepatocellular carcinoma, a type of primary liver cancer, and are most prevalent in people born 1945–1965. Relatively little information is available for liver cancer prevention, compared to other cancers. In this review, we provide a summary of current promising public health practices for liver cancer prevention from the literature, as well as liver cancer-related initiatives in the National Comprehensive Cancer Control Program (NCCCP).


Two types of source materials were analyzed for this review: published literature (2005-present), and current cancer plans from the NCCCP (2005–2022). A search strategy was developed to include a review of several scientific databases. Of the 73 articles identified as potentially eligible, 20 articles were eligible for inclusion in the review. Eligible articles were abstracted using a data abstraction tool. Three independent keyword searches on 65 NCCCP plans were conducted. Keyword searches within each of the plans to identify activities related to liver cancer were conducted. Relevant information was abstracted from the plans and saved in a data table.


Of the 20 eligible articles, 15 articles provided information on interventions related to liver cancer and hepatitis B or hepatitis C prevention. All 15 of the intervention articles were related to hepatitis; 13 were hepatitis B-focused, two were hepatitis C-focused, and 14 focused on Asian/Pacific Islander American populations. The independent keyword search of NCCCP plans produced 46 results for liver, 27 results for hepatitis, and 52 results for alcohol. Two plans included activities related to liver cancer. Twenty-four plans included activities related to hepatitis.


A majority of the intervention articles published focused on HBV infection in Asian/Pacific Islander American populations, and a small percentage of NCCCP plans included liver-related content. The findings from this review will inform the development of an Action Plan on liver cancer prevention for the NCCCP, which will assist programs with the adoption and uptake of promising practices for the prevention of liver cancer.


Comprehensive cancer control Carcinoma Hepatocellular Primary prevention Health promotion 


Compliance with ethical standards

Conflict of interest

The authors declare that they have no competing interests.


  1. 1.
    Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M et al (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136(5):E359–E386. CrossRefPubMedGoogle Scholar
  2. 2.
    U.S. Cancer Statistics Working Group (2017) United States Cancer Statistics: 1999–2014 incidence and mortality web-based report. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute, Atlanta.
  3. 3.
    Momin BR, Pinheiro PS, Carreira H, Li C, Weir HK (2017) Liver cancer survival in the United States by race and stage (2001–2009): findings from the CONCORD-2 study. Cancer 123(Suppl 24):5059–5078. CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Ryerson AB, Eheman CR, Altekruse SF et al (2016) Annual report to the nation on the status of cancer, 1975–2012, featuring the increasing incidence of liver cancer. Cancer 122:1312–1337CrossRefGoogle Scholar
  5. 5.
    Campbell PT, Newton CC, Freedman ND et al (2016) Body mass index, waist circumference, diabetes, and risk of liver cancer for US adults. Cancer Res 76:6076–6083CrossRefGoogle Scholar
  6. 6.
    Ahmed F, Perez JF, Jamison PM, Friedman C, Bell BP, Kwong S (2008) National trends and disparities in the incidence of hepatocellular carcinoma. Prev Chronic Dis 5(3):A74PubMedPubMedCentralGoogle Scholar
  7. 7.
    National Academies of Sciences, Engineering, and Medicine (2017) A national strategy for the elimination of hepatitis B and C: phase two report. The National Academies Press, Washington, DC. CrossRefGoogle Scholar
  8. 8.
    Schillie S, Vellozzi C, Reingold A et al (2018) Prevention of hepatitis B virus infection in the United States: recommendations of the advisory committee on immunization practices. MMWR Recomm Rep 67(1):1–31. RR- .CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    National Comprehensive Cancer Control Program (NCCCP). Accessed Sept 2017
  10. 10.
    Momin B, Richardson L (2012) An analysis of content in comprehensive cancer control plans that address chronic hepatitis B and C virus infections as major risk factors for liver cancer. J Community Health 37(4):912–916CrossRefGoogle Scholar
  11. 11.
    Cabibbo G, Maida M, Genco C, Antonucci M, Camma C (2012) Causes of and prevention strategies for hepatocellular carcinoma. Causes of prevention strategies for hepatocellular carcinoma. Semin Oncol 39(4):374–383CrossRefGoogle Scholar
  12. 12.
    Meyer JP et al (2015) Evidence-based interventions to enhance assessment, treatment, and adherence in the chronic hepatitis C care continuum. Int J Drug Policy 26(10):922–935CrossRefGoogle Scholar
  13. 13.
    Palmateer N et al (2010) Evidence for the effectiveness of sterile injecting equipment provision in preventing hepatitis C and human immunodeficiency virus transmission among injecting drug users: a review of reviews. Addiction 105(5):844–859CrossRefGoogle Scholar
  14. 14.
    Perez CM et al (2015) Tackling the health challenge posed by hepatitis C in Puerto Rico: a call for immediate public health actions. P R Health Sci J 34(2):53–59PubMedGoogle Scholar
  15. 15.
    Weinbaum CM, Williams I, Mast EE, Wang SA, Finelli L, Wasley A et al (2008) Centers for Disease Control and Prevention (CDC). Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. MMWR Recomm Rep 57(RR-8):1–20Google Scholar
  16. 16.
    Bastani R, Glenn BA, Maxwell AE, Jo AM, Herrmann AK et al (2015) Cluster-randomized trial to increase hepatitis B testing among Koreans in Los Angeles. Cancer Epidemiol Biomark Prev 24(9):1341–1349CrossRefGoogle Scholar
  17. 17.
    Chang ET et al (2009) 3 For life: a model pilot program to prevent hepatitis B virus infection and liver cancer in Asian and Pacific Islander Americans. Am J Health Promot 23(3):176–181CrossRefGoogle Scholar
  18. 18.
    Chao S, Chang E, Le P, Prapong W, Kiernan M, So S (2009) The Jade Ribbon campaign: a model program for community outreach and education to prevent liver cancer in Asian Americans. J Immigr Minor Health 11(4):281–290. CrossRefPubMedGoogle Scholar
  19. 19.
    Chen MS Jr, Fang DM, Stewart SL, Ly MY, Lee S, Dang JH et al (2013) Increasing hepatitis B screening for hmong adults: results from a randomized controlled community-based study. Cancer Epidemiol Biomark Prev. CrossRefGoogle Scholar
  20. 20.
    Hsu C, Liu L, Juon H, Chiu Y, Bawa J, Wang M et al (2007) Reducing liver cancer disparities: a community-based hepatitis-B prevention program for Asian-American communities. J Natl Med Assoc 99(8):900–907 8PubMedPubMedCentralGoogle Scholar
  21. 21.
    Hsu CE, Zhang G, Yan FA, Shang N, Le T (2010) What made a successful hepatitis B program for reducing liver cancer disparities: an examination of baseline characteristics and educational intervention, infection status, and missing responses of at-risk Asian Americans. J Community Health 35(3):325–335CrossRefGoogle Scholar
  22. 22.
    Hsu L, Bowlus CL, Stewart SL, Nguyen TT, Dang J, Chan B et al (2013) Electronic messages increase hepatitis B screening in at-risk Asian American patients: a randomized, controlled trial. Dig Dis Sci 58(3):807–814CrossRefGoogle Scholar
  23. 23.
    Juon H, Strong C, Oh T, Castillo T, Tsai G, Oh L (2008) Public health model for prevention of liver cancer among Asian Americans. J Community Health 33(4):199–205CrossRefGoogle Scholar
  24. 24.
    Juon HS, Lee S, Strong C, Rimal R, Kirk GD, Bowie J (2014) Effect of a liver cancer education program on hepatitis B screening among Asian Americans in the Baltimore-Washington metropolitan area, 2009–2010. Prev Chronic Dis 11:130258CrossRefGoogle Scholar
  25. 25.
    Ma GX, Zhang GY, Jung MY, Ma XS, Zhai S et al (2015) HCV screening behaviors and infection status among Vietnamese Americans. Am J Health Behav 39(5):640–651CrossRefGoogle Scholar
  26. 26.
    Marineau M, Tice AD, Taylor-Garcia D, Akinka KT, Lusk H, Ona F (2007) Culturally sensitive strategies designed to target the silent epidemic of Hepatitis B in a Filipino Community. Hawaii Med J 66:154–156PubMedGoogle Scholar
  27. 27.
    Maxwell AE, Bastani R, Glenn BA, Taylor VM, Nguyen TT, Stewart SL, Burke NJ, Chen MS (2014) Developing theoretically based and culturally appropriate interventions to promote hepatits B testing in 4 Asian American Populations, 2006–2011. Prev Chronic Dis 11:130245CrossRefGoogle Scholar
  28. 28.
    Norton BL et al (2014) Community-based HCV screening: knowledge and attitudes in a high risk urban population. BMC Infect Dis 14:74CrossRefGoogle Scholar
  29. 29.
    Taylor VM, Hislop TG, Tu SP, Teh C, Acorda E, Yip MP et al (2009) Evaluation of a hepatitis B lay health worker intervention for Chinese Americans and Canadians. J Community Health 34(3):165–172CrossRefGoogle Scholar
  30. 30.
    Taylor VM, Bastani R, Burke N, Talbot J, Sos C, Liu Q et al (2013) Evaluation of a hepatitis B lay health worker intervention for Cambodian Americans. J Community Health 38(3):546–553CrossRefGoogle Scholar
  31. 31.
    Bastani R, Glenn BA, Taylor VM, Chen MS, Nguyen TT, Stewart SL, Maxwell AE (2009) Integrating theory into community interventions to reduce liver cancer disparities: the health behavior framework. Prev Med 50(1–2):63–67PubMedPubMedCentralGoogle Scholar
  32. 32.
    Orlando R, Foggia M, Maraolo AE et al (2015) Prevention of hepatitis B virus infection: from the past to the future. Eur J Clin Microbiol Infect Dis 34(6):1059CrossRefGoogle Scholar
  33. 33.
  34. 34.
    Abara WE, Qaseem A, Schillie S, McMahon BJ, Harris AM, for the High Value Care Task Force of the American College of Physicians and the Centers for Disease Control and Prevention (2017) Hepatitis B, vaccination screening, and linkage to care: best practice advice from the American College of Physicians and the Centers for Disease Control and Prevention. Ann Intern Med 167:794–804. CrossRefPubMedGoogle Scholar
  35. 35.
    U.S. Preventive Services Task Force (2014) Final recommendation statement: hepatitis B, non-pregnant adolescents and adults, May 2014. U.S. Preventive Services Task Force, Rockville. Retrieved January 18, 2016, from StatementFinal/hepatitis-b-virus-infection-screening-2014
  36. 36.
    Millman AJ et al (2017) Barriers to treatment access for chronic hepatitis C virus infection: a case series. Top Antiviral Med 25(3):110Google Scholar
  37. 37.
    Smith BD, Morgan RL, Beckett GA, Falck-Ytter Y, Holtzman D, Teo CG et al (2012) Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945–1965. MMWR Recomm Rep 61(RR-4):1–32Google Scholar
  38. 38.
    Moyer VA (2013) Screening for hepatitis C virus infection in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 159(5):349–357. CrossRefPubMedGoogle Scholar
  39. 39.
    Jemal A, Fedewa SA (2015) Prevalence of hepatitis C virus testing in cohorts born between 1945 and 1965 in the U.S. Am J Prev Med 48(5):e7–e9. CrossRefPubMedGoogle Scholar
  40. 40.
    Centers for Disease Control and Prevention. Accessed on 23 Oct 2018

Copyright information

© This is a U.S. government work and its text is not subject to copyright protection in the United States; however, its text may be subject to foreign copyright protection 2018

Authors and Affiliations

  • Behnoosh Momin
    • 1
    Email author
  • Alexander J. Millman
    • 2
  • Danielle Beauchesne Nielsen
    • 3
  • Michelle Revels
    • 3
  • C. Brooke Steele
    • 1
  1. 1.Division of Cancer Prevention and ControlU.S. Centers for Disease Control and PreventionAtlantaUSA
  2. 2.Division of Viral HepatitisU.S. Centers for Disease Control and PreventionAtlantaUSA
  3. 3.ICFAtlantaUSA

Personalised recommendations